Alivus Life

60
Hold
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE03Q201024
  • NSEID: ALIVUS
  • BSEID: 543322
INR
1,319.40
-18.35 (-1.37%)
BSENSE

Oct 09

BSE+NSE Vol: 1.37 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 6.91% vs 4.54% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 16.80% vs 1.24% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 122.54% vs 56.14% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 16.24% vs 3.13% in Mar 2025

Compare Profit and Loss Results of Alivus Life
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
2,551.00
2,030.00
521.00
25.67%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
2,551.00
2,030.00
521.00
25.67%
Expenditure (Ex Depriciation)
Stock Adjustments
3.00
-38.00
41.00
107.89%
Raw Materials Consumed
1,063.00
691.00
372.00
53.84%
Power & Fuel Cost
113.00
109.00
4.00
3.67%
Employee Cost
272.00
380.00
-108.00
-28.42%
Operating Expenses
173.00
213.00
-40.00
-18.78%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
56.00
47.00
9.00
19.15%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
39.00
39.00
0.00
0.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,754.00
1,576.00
178.00
11.29%
Operating Profit (PBDIT) excl Other Income
797.00
454.00
343.00
75.55%
Other Income
60.00
44.00
16.00
36.36%
Operating Profit (PBDIT)
857.00
499.00
358.00
71.74%
Interest
5.00
22.00
-17.00
-77.27%
Profit before Depriciation and Tax
852.00
476.00
376.00
78.99%
Depreciation
75.00
133.00
-58.00
-43.61%
Profit Before Taxation & Exceptional Items
776.00
343.00
433.00
126.24%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
751.00
313.00
438.00
139.94%
Provision for Tax
186.00
84.00
102.00
121.43%
Profit After Tax
564.00
228.00
336.00
147.37%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1,777.00
2,739.00
-962.00
-35.12%
Profit Available for appropriations
2,341.00
2,968.00
-627.00
-21.13%
Appropriations
2,341.00
2,968.00
-627.00
-21.13%
Equity Dividend (%)
250%
0%
250.00
Earnings Per Share
45.99
5.98
40.01
669.06%
Profit And Loss - Net Sales
Net Sales 2,551.83 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 6.91% vs 4.54% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 797.28 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 16.80% vs 1.24% in Mar 2025

Profit And Loss - Interest
Interest 5.37 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 122.54% vs 56.14% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 564.48 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 16.24% vs 3.13% in Mar 2025